ASO Visual Abstract: Results of a Randomized Clinical Study of Gemcitabine Plus Nab-Paclitaxel versus Gemcitabine Plus S-1 as Neoadjuvant Chemotherapy for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma (RCT, CSGO-HBP-015)

期刊论文
发表日期：

2024年5月25日

查看全文

Daisaku Yamada,
Shogo Kobayashi,
Hidenori Takahashi,
Yoshifumi Iwagami,
Hirofumi Akita,
Kei Asukai,
Junzo Shimizu,
Terumasa Yamada,
Masahiro Tanemura,
Shigekazu Yokoyama,
Masanori Tsujie,
Tadafumi Asaoka,
Yutaka Takeda,
Osakuni Morimoto,
Akira Tomokuni,
Yuichiro Doki,
Hidetoshi Eguchi

本文未提供摘要，请点击“查看全文”查看完整内容。